Thyrocare Technologies Ltd. Conference Calls and Earnings Call Transcripts

Thyrocare Technologies Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Thyrocare Technologies Ltd.
18 Aug 2018
1205.90
0.94%
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held on Tuesday, August 14, 2018 at 11.00 A.M. local time, to discuss the Company's Unaudited financial results (Stand-alone and Consolidated) for Quarter ended June 30, 2018. Dr. Velumani A., Ph.D., CEO, Mr. A. Sundararaju, CFO, Mr. Sachin Salvi, GM-Finance and Mr. Vatsal Goyal,...
pdf
logo
Thyrocare Technologies Ltd.
17 Jul 2018
1205.90
0.94%
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Sudarshan Padmanabhan, Research Analyst-Investment of Sundaram Asset Management Company Limited, would be having a meeting with our Chairman & Managing Director, Dr. A. Velumani, at our office by 12.00 Noon on Wednesday, July 18, 2018....
pdf
logo
Thyrocare Technologies Ltd.
07 Jun 2018
1205.90
0.94%
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Ashwin Reddy of Samatva Investments, would be having a meeting with our General Manger-Finance, Mr. Sachin Salvi, at our office by 11.00 A.M. on Friday, June 8, 2018. There could be one or more representatives, and there could be last minute change in timings....
pdf
logo
Thyrocare Technologies Ltd.
23 May 2018
1205.90
0.94%
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Ms. Roopa Raman of International Finance Corporation (IFC), would be having a meeting with our General Manger-Finance, Mr. Sachin Salvi and Head-Strategy and Corporate Development, Mr. Vatsal Goyal, at our office by 11.00 A.M. today (Wednesday, 23rd May 2018)....
pdf
logo
Thyrocare Technologies Ltd.
09 May 2018
1205.90
0.94%
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held on Thursday, May 03, 2018 at 3.00 P.M. local time, to discuss the Company's Audited financial results (Stand-alone and Consolidated) for Quarter/ Year ended March 31, 2018. Dr. Velumani A., Ph.D., CEO, Mr. A. Sundararaju, CFO and Mr. Sachin Salvi, GM-Finance and Mr. Vatsal...
pdf
logo
Thyrocare Technologies Ltd.
12 Feb 2018
1205.90
0.94%
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held to discuss the Company's unaudited financial results for Quarter/Nine Months ended December 31, 2017, on Friday, February 09, 2018 at 02.30 P.M. local time. Dr. Velumani A., Ph.D., CEO, Mr. A. Sundararaju, CFO, Mr. Sachin Salvi, GM-Finance and Mr. Vatsal Goyal, Head-Strategy...
pdf
logo
Thyrocare Technologies Ltd.
15 Dec 2017
1205.90
0.94%
Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held to discuss the Company's unaudited financial results (stand-alone and consolidated) for Quarter/Half Year ended September 30, 2017, on Tuesday, December 12, 2017 at 2.30 P.M. local time. Dr. Velumani A., Ph.D., CEO, Mr. A. Sundararaju, CFO and Mr. Sachin Salvi, GM-Finance, represented the Company.
pdf

Earnings Calls Podcast on